Talking therapy may restore dignity in final months of cancer
NCT ID NCT06105359
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a talking therapy called dignity therapy can improve feelings of dignity and self-esteem in people with end-stage cancer. 48 patients were randomly assigned to receive either dignity therapy or usual care. The therapy involved five sessions discussing personal questions to help patients reflect on their lives. The goal was to see if this approach could ease emotional distress and improve quality of life in the final months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dignity therapy (a structured psychological intervention)
- What this could lead to
- If it works, this could offer a simple, non-drug way to help terminally ill cancer patients feel more dignified and improve their self-esteem.
- What could go wrong
- This is a small, completed study with only 48 participants, so results may not apply to everyone. The therapy is supportive and carries no physical risks, but its benefits may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
48 people
The number who actually took part.
- Started
-
Jan 2023
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Inclusion Criteria for Participants in the Study: * Able to speak and understand Turkish, * Those over 18 years of age * No communication barriers * Cancer diagnosis is in the 4th stage and in the last stage * Patients with a predicted survival time of less than 6 months (physician opinion) will be included Exclusion Criteria: * Criteria for Exclusion of Participants in the Study: * Those diagnosed with dementia, delirium or other organic brain disorders; * Those with impaired consciousness; * Patients with mental problems that prevent them from receiving esteem therapy will be excluded
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Necmettin Erbakan Üniversitesi
Konya, 42080, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Can a gentler blood thinner shield cancer patients from new clots?
- Can more phone calls after cancer surgery keep patients out of the hospital?
- Live music meets virtual reality: can a Three-Session program reach advanced cancer patients in palliative care?
- Matching cancer survivors to the right level of support
- Can colorectal surgery patients go home in two days?